Denver Business News
22 September 2010
An experimental cervical cancer vaccine developed by researchers at the University of Colorado Cancer Center in Aurora is ready to begin testing in human clinical trials, the center announced.
The vaccine is intended to be less expensive than others now available and therefore better suited for developing countries such as India where the disease is rampant, UCCC officials said.
Leave a Reply